Doxycycline ameliorates aggregation of collagen and atrial natriuretic peptide in murine post-infarction heart

European Journal of Pharmacology

Volumn 754, Issue , 2015, Pages 66-72

  Zhu, Hongjun ^a   Sun, Xianlin ^a   Wang, Deguo ^b   Hu, Nengwei ^b,c   Zhang, Yao ^b  

^a ANHUI PROVINCIAL HOSPITAL   (China)

^b WANNAN MEDICAL COLLEGE   (China)

^c TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Atrial natriuretic peptide (ANP); Autophagy; Doxycycline; Matrix metalloproteinase (MMP); Myocardial infarction (MI)

Indexed keywords

ATRIAL NATRIURETIC FACTOR; COLLAGEN TYPE 1; DOXYCYCLINE; GELATINASE A; GELATINASE B; MICROTUBULE ASSOCIATED PROTEIN 1; MICROTUBULE ASSOCIATED PROTEIN 1 LIGHT CHAIN 3; UNCLASSIFIED DRUG; LC3 PROTEIN, RAT; MATRIX METALLOPROTEINASE; MICROTUBULE ASSOCIATED PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CARDIOVASCULAR PARAMETERS; CELL SIZE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; GENERAL PATHOLOGICAL PARAMETERS; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICULAR END DIASTOLIC DIAMETER; HEART LEFT VENTRICULAR END SYSTOLIC DIAMETER; HEART LEFT VENTRICULAR FRACTIONAL SHORTENING; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; INFARCT SIZE; MALE; MOLECULAR DYNAMICS; MYOCARDIAL INFARCTION INDUCED HEART FAILURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; RAT; TREATMENT DURATION; ZYMOGRAPHY; ANIMAL; CARDIAC MUSCLE; COMPLICATION; DRUG EFFECTS; HEART; HEART VENTRICLE REMODELING; METABOLISM; MYOCARDIAL INFARCTION; PATHOLOGY; PHAGOSOME;

ANIMALS; ATRIAL NATRIURETIC FACTOR; COLLAGEN TYPE I; DOXYCYCLINE; ECHOCARDIOGRAPHY; HEART; HEART FAILURE; MALE; MATRIX METALLOPROTEINASES; MICROTUBULE-ASSOCIATED PROTEINS; MYOCARDIAL INFARCTION; MYOCARDIUM; PHAGOSOMES; RATS; VENTRICULAR REMODELING;

EID: 84929311083     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2015.02.026     Document Type: Article

References (27)

1. G. Cerisano, P. Buonamici, R. Valenti, G. Moschi, E. Taddeucci, L. Giurlani, A. Migliorini, R. Vergara, G. Parodi, R. Sciagra, R. Romito, P. Colonna, and D. Antoniucci Effects of a timely therapy with doxycycline on the left ventricular remodeling according to the pre-procedural TIMI flow grade in patients with ST-elevation acute myocardial infarction Basic Res. Cardiol. 109 2014 412
2. G. Cerisano, P. Buonamici, R. Valenti, R. Sciagra, S. Raspanti, A. Santini, N. Carrabba, E.V. Dovellini, R. Romito, A. Pupi, P. Colonna, and D. Antoniucci Early short-term doxycycline therapy in patients with acute myocardial infarction and left ventricular dysfunction to prevent the ominous progression to adverse remodelling: the TIPTOP trial Eur. Heart J. 35 2014 184 191
3. W. Dai, S.L. Hale, B.J. Martin, J.Q. Kuang, J.S. Dow, L.E. Wold, and R.A. Kloner Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects Circulation 112 2005 214 223
4. F. Del Monte, and G. Agnetti Protein post-translational modifications and misfolding: new concepts in heart failure Proteomics Clin. Appl. 8 2014 534 542
5. P.W. Fedak, S.M. Altamentova, R.D. Weisel, N. Nili, N. Ohno, S. Verma, T.Y. Lee, C. Kiani, D.A. Mickle, B.H. Strauss, and R.K. Li Matrix remodeling in experimental and human heart failure: a possible regulatory role for TIMP-3 Am. J. Physiol. Heart Circ. Physiol. 284 2003 H626 H634
6. R.A. Garcia, K.V. Go, and F.J. Villarreal Effects of timed administration of doxycycline or methylprednisolone on post-myocardial infarction inflammation and left ventricular remodeling in the rat heart Mol. Cell. Biochem. 300 2007 159 169
7. J.Y. Hahn, H.J. Cho, H.J. Kang, T.S. Kim, M.H. Kim, J.H. Chung, J.W. Bae, B.H. Oh, Y.B. Park, and H.S. Kim Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction J. Am. Coll. Cardiol. 51 2008 933 943
8. S.Y. Hung, W.P. Huang, H.C. Liou, and W.M. Fu Autophagy protects neuron from Abeta-induced cytotoxicity Autophagy 5 2009 502 510
9. H. Kanamori, G. Takemura, K. Goto, R. Maruyama, A. Tsujimoto, A. Ogino, T. Takeyama, T. Kawaguchi, T. Watanabe, T. Fujiwara, H. Fujiwara, M. Seishima, and S. Minatoguchi The role of autophagy emerging in postinfarction cardiac remodelling Cardiovasc. Res. 91 2011 330 339
10. T.P. Knowles, M. Vendruscolo, and C.M. Dobson The amyloid state and its association with protein misfolding diseases Nat. Rev. Mol. Cell Biol. 15 2014 384 396
11. A.H. Li, P.P. Liu, F.J. Villarreal, and R.A. Garcia Dynamic changes in myocardial matrix and relevance to disease: translational perspectives Circ. Res. 114 2014 916 927
12. N.N. Louros, V.A. Iconomidou, P.L. Tsiolaki, E.D. Chrysina, G.E. Baltatzis, E.S. Patsouris, and S.J. Hamodrakas An N-terminal pro-atrial natriuretic peptide (NT-proANP) 'aggregation-prone' segment involved in isolated atrial amyloidosis FEBS Lett. 588 2014 52 57
13. L. Millucci, L. Ghezzi, G. Bernardini, D. Braconi, P. Tanganelli, and A. Santucci Prevalence of isolated atrial amyloidosis in young patients affected by congestive heart failure Sci. World J. 2012 2012 293863
14. L. Millucci, E. Paccagnini, L. Ghezzi, G. Bernardini, D. Braconi, M. Laschi, M. Consumi, A. Spreafico, P. Tanganelli, P. Lupetti, A. Magnani, and A. Santucci Different factors affecting human ANP amyloid aggregation and their implications in congestive heart failure PloS One 6 2011 e21870
15. S.F. Mohammed, S.A. Mirzoyev, W.D. Edwards, A. Dogan, D.R. Grogan, S.M. Dunlay, V.L. Roger, M.A. Gertz, A. Dispenzieri, S.R. Zeldenrust, and M.M. Redfield Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction JACC Heart Fail. 2 2014 113 122
16. E.L. Olivares, V.P. Ribeiro, J.P. Werneck de Castro, K.C. Ribeiro, E.C. Mattos, R.C. Goldenberg, J.G. Mill, H.F. Dohmann, R.R. dos Santos, A.C. de Carvalho, and M.O. Masuda Bone marrow stromal cells improve cardiac performance in healed infarcted rat hearts Am. J. Physiol. Heart Circ. Physiol. 287 2004 H464 H470
17. J.S. Pattison, A. Sanbe, A. Maloyan, H. Osinska, R. Klevitsky, and J. Robbins Cardiomyocyte expression of a polyglutamine preamyloid oligomer causes heart failure Circulation 117 2008 2743 2751
18. M.A. Pfeffer Left ventricular remodeling after acute myocardial infarction Annu. Rev. Med. 46 1995 455 466
19. M.A. Pfeffer, and E. Braunwald Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications Circulation 81 1990 1161 1172
20. A. Pucci, J. Wharton, E. Arbustini, M. Grasso, M. Diegoli, P. Needleman, M. Vigano, and J.M. Polak Atrial amyloid deposits in the failing human heart display both atrial and brain natriuretic peptide-like immunoreactivity J. Pathol. 165 1991 235 241
21. J.L. Rouleau, J. de Champlain, M. Klein, D. Bichet, L. Moye, M. Packer, G.R. Dagenais, B. Sussex, J.M. Arnold, and F. Sestier Activation of neurohumoral systems in postinfarction left ventricular dysfunction J. Am. Coll. Cardiol. 22 1993 390 398
22. T.N. Sidorova, L.C. Mace, K.S. Wells, L.V. Yermalitskaya, P.F. Su, Y. Shyr, J.G. Byrne, M.R. Petracek, J.P. Greelish, S.J. Hoff, S.K. Ball, C.G. Glabe, N.J. Brown, J.V. Barnett, and K.T. Murray Quantitative imaging of preamyloid oligomers, a novel structural abnormality, in human atrial samples J. Histochem. Cytochem. 62 2014 479 487
23. F.G. Spinale Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function Physiol. Rev. 87 2007 1285 1342
24. P. Tannous, H. Zhu, J.L. Johnstone, J.M. Shelton, N.S. Rajasekaran, I.J. Benjamin, L. Nguyen, R.D. Gerard, B. Levine, B.A. Rothermel, and J.A. Hill Autophagy is an adaptive response in desmin-related cardiomyopathy Proc. Natl. Acad. Sci. USA 105 2008 9745 9750
25. J.E. Ward, R. Ren, G. Toraldo, P. Soohoo, J. Guan, C. O'Hara, R. Jasuja, V. Trinkaus-Randall, R. Liao, L.H. Connors, and D.C. Seldin Doxycycline reduces fibril formation in a transgenic mouse model of AL amyloidosis Blood 118 2011 6610 6617
26. M.S. Willis, and C. Patterson Proteotoxicity and cardiac dysfunction-Alzheimer's disease of the heart? New Engl. J. Med. 368 2013 455 464
27. H. Zheng, M. Tang, Q. Zheng, A.R. Kumarapeli, K.M. Horak, Z. Tian, and X. Wang Doxycycline attenuates protein aggregation in cardiomyocytes and improves survival of a mouse model of cardiac proteinopathy J. Am. Coll. Cardiol. 56 2010 1418 1426